These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 9766719

  • 41. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    Bannas P, Weber C, Adam G, Frenzel T, Derlin T, Mester J, Klutmann S.
    Int J Radiat Oncol Biol Phys; 2011 Oct 01; 81(2):445-51. PubMed ID: 20832181
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Positron emission tomography in the staging of esophageal cancer.
    Leccisotti L.
    Rays; 2006 Oct 01; 31(1):9-12. PubMed ID: 16999368
    [Abstract] [Full Text] [Related]

  • 46. [FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].
    Yuan SH, Yu JM, Yu YH, Fu Z, Guo HB, Liu TH, Yang XH, Yang GR, Li WW.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 01; 29(3):221-4. PubMed ID: 17649642
    [Abstract] [Full Text] [Related]

  • 47. Will Rogers phenomenon in the oesophageal cancer patients staging - CT versus 18F-FDG PET/CT: retrospective study.
    Pietrzak AK, Martenka P, Strzesak E, Wierzchoslawska E, Marszałek A, Pietrasz K, Cholewiński W.
    Hell J Nucl Med; 2019 Mar 01; 22 Suppl 2():174-180. PubMed ID: 31802058
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. The Prognostic Role of Pre-operative Positron Emission Tomography-Computed Tomography and Endoscopic Ultrasound Parameters in Oesophageal Adenocarcinoma.
    Dellaportas D, Zylstra J, Gossage J, Baker C, Kelly M, Hemelrijck MV, Griffin N, Lagergren J, Davies AR.
    Chirurgia (Bucur); 2019 Mar 01; 114(4):443-450. PubMed ID: 31511130
    [Abstract] [Full Text] [Related]

  • 50. Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy.
    Machiels M, Wouterse SJ, Geijsen ED, van Os RM, Bennink RJ, van Laarhoven HW, Hulshof MC.
    J Med Imaging Radiat Oncol; 2016 Aug 01; 60(4):520-7. PubMed ID: 27197751
    [Abstract] [Full Text] [Related]

  • 51. 18FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma.
    Lehmann K, Eshmuminov D, Bauerfeind P, Gubler C, Veit-Haibach P, Weber A, Abdul-Rahman H, Fischer M, Reiner C, Schneider PM.
    Eur J Surg Oncol; 2017 Jan 01; 43(1):196-202. PubMed ID: 27692533
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Staging in oesophageal cancer.
    Plukker JT, van Westreenen HL.
    Best Pract Res Clin Gastroenterol; 2006 Jan 01; 20(5):877-91. PubMed ID: 16997167
    [Abstract] [Full Text] [Related]

  • 54. Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
    Tan R, Yao SZ, Huang ZQ, Li J, Li X, Tan HH, Liu QW.
    Asian Pac J Cancer Prev; 2014 Jan 01; 15(18):7719-24. PubMed ID: 25292052
    [Abstract] [Full Text] [Related]

  • 55. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
    Kim HJ, Cho A, Yun M, Kim YT, Kang WJ.
    Ann Nucl Med; 2016 Feb 01; 30(2):104-13. PubMed ID: 26546334
    [Abstract] [Full Text] [Related]

  • 56. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.
    Choi JY, Lee KH, Shim YM, Lee KS, Kim JJ, Kim SE, Kim BT.
    J Nucl Med; 2000 May 01; 41(5):808-15. PubMed ID: 10809196
    [Abstract] [Full Text] [Related]

  • 57. Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
    Vesprini D, Ung Y, Dinniwell R, Breen S, Cheung F, Grabarz D, Kamra J, Mah K, Mansouri A, Pond G, Brock K, Darling G, Knox J, Haider M, Wong RK.
    Clin Oncol (R Coll Radiol); 2008 Oct 01; 20(8):631-8. PubMed ID: 18755578
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
    Fuster D, Duch J, Paredes P, Velasco M, Muñoz M, Santamaría G, Fontanillas M, Pons F.
    J Clin Oncol; 2008 Oct 10; 26(29):4746-51. PubMed ID: 18695254
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.